Abstract
Get full access to this article
View all access options for this article.
References
1.
.
Walsh
TJ
,
Pappas
P
,
Winston
DJ
,
Lazarus
HM
,
Petersen
F
,
Rafalli
J
, Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever . N Engl J Med
2002 ; 346 : 225 –34 .
2.
.
Naranjo
CA
,
Busto
U
,
Sellers
EM
,
Sandor
P
,
Ruiz
I
,
Roberts
EA
, A method for estimating the probability of adverse drug reactions . Clin Pharmacol Ther
1981 ; 30 : 239 –45 .
3.
.
Herbrecht
R
,
Denning
DW
,
Patterson
TF
,
Bennett
JE
,
Greene
RE
,
Oestmenn
JW
, Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis . N Engl J Med
2002 ; 347 : 408 –15 .
4.
. Package insert. Vfend (voriconazole) . New York : Pfizer , 2002 .